Victor Cervera-Carrascon
10PUBLICATIONS
36CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Apr 10, 2026
Alistipes and Eggerthella shape the response to oncolytic adenovirus therapy in mice and humans through short-chain fatty acid metabolism.Mirte van der Heijden, James Hugo Armstrong Clubb, Pande Putu Erawijantari
|Mar 28, 2024
Safety, Efficacy, and Biological Data of T-Cell-Enabling Oncolytic Adenovirus TILT-123 in Advanced Solid Cancers from the TUNIMO Monotherapy Phase I Trial.Santeri A Pakola, Katriina J Peltola, James H A Clubb
|Jan 27, 2022
Local therapy with an engineered oncolytic adenovirus enables antitumor response in non-injected melanoma tumors in mice treated with aPD-1.Dafne C A Quixabeira, Victor Cervera-Carrascon, Joao M Santos
|Oct 23, 2021
Enhanced Stability and Bioactivity of Natural Anticancer Topoisomerase I Inhibitors through Cyclodextrin Complexation.Víctor González-Ruiz, Ángel Cores, Olmo Martín-Cámara
|Apr 30, 2021
Systemic Delivery of Oncolytic Adenovirus to Tumors Using Tumor-Infiltrating Lymphocytes as Carriers.Joao Santos, Camilla Heiniö, Dafne Quixabeira
|Jan 30, 2021
Cytokine-Coding Oncolytic Adenovirus TILT-123 Is Safe, Selective, and Effective as a Single Agent and in Combination with Immune Checkpoint Inhibitor Anti-PD-1.Riikka Havunen, Riikka Kalliokoski, Mikko Siurala
Pageof 2
Frequent Collaborators
4 joint publications
Dafne Quixabeira
4 joint publications
Akseli Hemminki
3 joint publications
James Hugo Armstrong Clubb
3 joint publications
Santeri Artturi Pakola
3 joint publications
Tatiana V Kudling
2 joint publications
Elise Jirovec
2 joint publications
Marjukka Anttila
2 joint publications
Camilla Heiniö
2 joint publications
Mirte van der Heijden
2 joint publications
Lyna Haybout
